Focused Wealth Management, Inc

Position in GILD — Gilead Sciences, Inc.

CIK 1586052 Newburgh, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$225,390

+$135,145 QoQ

Shares Held

1,784

+60.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#1,849

of 2,266 holders

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Focused Wealth Management, Inc holds $11,871,008 across 7 Drug Manufacturers - General names. GILD ranks #7 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	119,833	$2,885,578
2	LLY	ELI LILLY & Co	2,178	$2,612,358
3	ABBV	AbbVie Inc.	9,724	$2,446,947
4	JNJ	Johnson & Johnson	8,891	$2,258,047
5	MRK	Merck & Co., Inc.	7,826	$1,005,641
6	BMY	Bristol Myers Squibb Co	7,585	$437,047
7	GILD	Gilead Sciences, Inc. This page	1,784	$225,390

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$225,390	1,784	+60.1%	Shares	Sole	2026-08-07
2023-12-31	$90,245	1,114	+0.4%	Shares	Sole	2024-01-10
2023-09-30	$83,183	1,110	+0.5%	Shares	Sole	2023-11-01
2023-06-30	$85,162	1,105	-21.1%	Shares	Sole	2023-08-08
2023-03-31	$116,158	1,400	-8.0%	Shares	Sole	2023-04-13
2022-12-31	$130,577	1,521	+0.3%	Shares	Sole	2023-01-13
2022-09-30	$93,583	1,517	+0.3%	Shares	Sole	2022-10-20
2022-06-30	$93,456	1,512	-0.8%	Shares	Sole	2022-08-04
2022-03-31	$90,601	1,524	+0.4%	Shares	Sole	2022-04-29
2021-12-31	$110,221	1,518	-5.5%	Shares	Sole	2022-01-31
2021-09-30	$112,179	1,606	+1.5%	Shares	Sole	2021-10-12
2021-06-30	$109,005	1,583	+0.4%	Shares	Sole	2021-07-15
2021-03-31	$101,921	1,577	-5.7%	Shares	Sole	2021-05-03
2020-12-31	$97,468	1,673	+25.7%	Shares	Sole	2021-02-03
2020-09-30	$84,105	1,331	-7.8%	Shares	Sole	2020-10-19
2020-06-30	$111,101	1,444	+45.9%	Shares	Sole	2020-07-24
2020-03-31	$74,012	990	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.